Literature DB >> 24969199

Scleroderma renal crisis in a case of mixed connective tissue disease.

Mukul Vij1, Vinita Agrawal, Manoj Jain.   

Abstract

Mixed connective tissue disease (MCTD) is an overlap syndrome first defined in 1972 by Sharp et al. In this original study, the portrait emerged of a connective tissue disorder sharing features of systemic lupus erythematosus, systemic sclerosis (scleroderma) and polymyositis. Scleroderma renal crisis (SRC) is an extremely infrequent but serious complication that can occur in MCTD. The histologic picture of SRC is that of a thrombotic micro-angiopathic process. Renal biopsy plays an important role in confirming the clinical diagnosis, excluding overlapping/superimposed diseases that might lead to acute renal failure in MCTD patients, helping to predict the clinical outcome and optimizing patient management. We herewith report a rare case of SRC in a patient with MCTD and review the relevant literature.

Entities:  

Mesh:

Year:  2014        PMID: 24969199     DOI: 10.4103/1319-2442.135177

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  3 in total

1.  Scleroderma Renal Crisis in a Case of Mixed Connective Tissue Disease Treated Successfully with Angiotensin-Converting Enzyme Inhibitors.

Authors:  Jomana Madieh; Iman Khamayseh; Alaa Hrizat; Abdurrahman Hamadah; Kamel Gharaibeh
Journal:  Case Rep Nephrol       Date:  2021-01-06

2.  The dilemma: scleroderma renal crisis vs lupus nephritis in a patient with mixed connective tissue disorder.

Authors:  Nicola Jackson; Shion Betty; James Appiah-Pippim; Yolin Bueno; Sana Makhdumi
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-11-15

3.  Scleroderma Renal Crisis in Mixed Connective Tissue Disease With Full Renal Recovery Within 3 Months: A Case Report With Expanding Treatment Modalities to Treat Each Clinical Sign as an Independent Entity.

Authors:  Jordana Cheta; Suresh Rijhwani; Harlan Rust
Journal:  J Investig Med High Impact Case Rep       Date:  2017-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.